All

Results: 16297-16308 of 71466

Survey: 86% of Companies Fast-Track Global Hiring as Domestic Pressures Mount

PR Newswire associated0

NYSE Content Advisory: Pre-Market Update + Grand Ole Opry Celebrates 100th Anniversary

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Bloomberg New Economy Introduces the 2025 Class of Catalysts: Innovators Shaping a More Resilient, Inclusive Global Future

PR Newswire associated0

TrueLayer to Acquire Zimpler, Creating a European Pay by Bank Powerhouse

Vertex Announces CEO Retirement and Succession Plan

KBRA Assigns Preliminary Ratings to Temple Quay No.2 PLC

PR Newswire associated0

Kahua Launches Enterprise AI: A Security-First Approach to Transforming Capital Program Management

PR Newswire associated0

Mesh Suture, Inc. Secures Key Regulatory Approvals, Accelerating Global Access to DURAMESH™ for Surgeons Worldwide

Researchers at Chemify’s first Chemifarm—a fully automated chemistry facility regarded as the world’s most advanced laboratory for molecular design and synthesis, which opened in Glasgow, Scotland in June of 2025. Chemify, the deep-tech pioneer fusing chemistry, robotics, computation, and Chemputation—Chemify’s purpose-built AI to digitize molecule creation—announced today it has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. Co-led by Wing Venture Capital and Insight Partners, the financing will scale Chemify’s Chemputation platform and Chemifarm facilities, transforming how molecules are designed and made for medicines and advanced materials.

Chemify Raises More Than $50 Million in Oversubscribed Series B to Drive Global Expansion of Digital Chemistry and Discovery

PR Newswire associated0

Corporate AI Training in the AI Bubble Era: Teamland Urges Leaders to Invest in People Over Hype

PR Newswire associated0

Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics